Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Revance Therapeutics, Inc.Listing unverified | Other | $25.3K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Sell | $9.1K | SEC |